Dana N. Loury

Identification of a single α₁‐adrenoceptor corresponding to the α_1A‐subtype in rat submaxillary gland

Anton D. Michel, Dana N. Loury, R.L. Whiting · British Journal of Pharmacology · 1989 · 112 citations · Full text

Medicine, Pharmacology, Biochemical Pharmacology +9

Differences between the α₂‐adrenoceptor in rat submaxillary gland and the α_2A‐ and α_2B‐adrenoceptor subtypes

Anton D. Michel, Dana N. Loury, R.L. Whiting · British Journal of Pharmacology · 1989 · 102 citations · Full text

Medicine, Biochemistry, Pharmacology +7

[3H]BIMU-1, a 5-hydroxytryptamine3 receptor ligand in NG-108 cells, selectively labels sigma-2 binding sites in guinea pig hippocampus.

D W Bonhaus, Dana N. Loury, Lyn B. Jakeman et al. · Journal of Pharmacology and Experimental Therapeutics · 1993 · 60 citations · Full text

Medicine, Neuroscience, Pharmacology +13

Characteristics of 5‐HT₃ binding sites in NG108‐15, NCB‐20 neuroblastoma cells and rat cerebral cortex using [³H]‐quipazine and [³H]‐GR65630 binding

Naj Sharif, Erik H.F. Wong, Dana N. Loury et al. · British Journal of Pharmacology · 1991 · 56 citations · Full text

Medicine, Neuroscience, Pharmacology +16

Assessment of imiloxan as a selective α_2B‐adrenoceptor antagonist

Anton D. Michel, Dana N. Loury, R.L. Whiting · British Journal of Pharmacology · 1990 · 50 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12